CJ
Christopher John Kenney sold $426K of XENE stock
Christopher John Kenney, Chief Medical Officer of Xenon Pharmaceuticals Inc. (XENE), sold 7,068 shares of XENE stock worth $426K, per an SEC Form 4 filed Sep 1, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 28, 2026, 4 days before it was made public.
XENE has moved -34.7% since the trade date, from $59.99 to $39.17 (Nov 6, 2026 close).
- Traded
- Aug 28, 2026
- Disclosed
- Sep 1, 2026
- Filing delay
- 4 days
- Price since
- -34.7%
- Role
- Chief Medical Officer
- Source
- SEC Form 4